Anew Medical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WENA research report →
Price Chart
About the company
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders.
- CEO
- Joseph Sinkule
- Employees
- 1
- HQ
- Omaha, NE, US
Get TickerSpark's AI analysis on WENA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $15.44M
- P/E
- 5.19
- PEG
- -0.05
- P/S
- 0.00
- P/B
- 0.63
- EV/EBITDA
- -12.97
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 2.16%
- ROIC
- -5.00%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-1,300,840
- Net Income
- $1.35M+9.1%
- EPS
- $0.14+69.3%
- OCF Growth
- -156.1%
- FCF Growth
- -104.2%
- 52W High
- $5.11
- 52W Low
- $0.70
- 50D MA
- $1.04
- 200D MA
- $1.28
- Beta
- 0.02
- RSI (14)
- 32
- Avg Volume
- 1.79M
No earnings-call transcripts are available for WENA yet.
- Free Float
- 59.8%
- Shares Outstanding
- 21.26M
- Float Shares
- 12.71M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 28, 24 | CHARDAN CAPITAL MARKETS LLC | sell | 47,000 |
| Jul 1, 24 | CHARDAN CAPITAL MARKETS LLC | sell | 115,136 |
| Jul 2, 24 | CHARDAN CAPITAL MARKETS LLC | sell | 180,000 |
| Jun 21, 24 | CHARDAN CAPITAL MARKETS LLC | other | 0 |
| Jun 21, 24 | CHARDAN CAPITAL MARKETS LLC | other | 724,500 |
| Jun 21, 24 | CHARDAN CAPITAL MARKETS LLC | other | 115,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our WENA coverage
Recent articles, reports, and earnings notes.
No research on WENA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WENA report →ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
prismmediawire.com · Sep 17
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
globenewswire.com · Sep 17
Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy
prismmediawire.com · Sep 4
Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy
globenewswire.com · Sep 4
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
prismmediawire.com · Aug 26
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
globenewswire.com · Aug 26
ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)
prismmediawire.com · Aug 21
ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)
globenewswire.com · Aug 21
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.